Market Overview

Tyson Foods Reports Mixed Q3 Earnings

Tyson Foods Reports Mixed Q3 Earnings

Tyson Foods (NYSE: TSN) reported third-quarter earnings of $1.47 per share, which beat the analyst consensus estimate of $1.45 by 1.38%. This is a 2% decrease over earnings of $1.50 per share from the same period last year.

The company reported quarterly sales of $10.885 billion, which missed the analyst consensus estimate of $11.08 billion by 1.76%. This is a 8.30% increase over sales of $10.051 billion the same period last year.

Tyson Foods reaffirmed fiscal year 2019 EPS guidance at $5.75-6.10 versus a $5.89 analyst estimate.

"Overall, third-quarter earnings were in line with our expectations," said Noel White, Tyson CEO. "Volume growth in our core retail lines continues to outpace other large food companies and the total food and beverage category, driven primarily by our new product innovation. Our Prepared Foods and Beef segments produced strong results in the quarter, while results in the Chicken segment were mixed, and the Pork segment was negatively affected by increased hog costs."

Tyson Foods shares were trading up 0.74% at $80.35 in Monday’s pre-market session. The stock has a 52-week high of $84.30 and a 52-week low of $49.77.

Related Links:

Boise Cascade Reports Mixed Q2 Earnings

Jacobs Engineering Reports Q3 Earnings Beat

Posted-In: Earnings News Guidance Best of Benzinga


Related Articles (TSN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

The Week Ahead In Cannabis: Cronos And GW Pharma Earnings, Ontario's Second License Lottery

Eli Lilly Announces Positive Results For Emgality